中国肝脏病杂志(电子版)

位置：首页 >> 期刊文章

树突状细胞治疗42例核苷（酸）类似物和（或）干扰素经治慢性乙型肝炎患者的临床研究

作者：顾生旺 1 高凯旋 2 刘欢 1 周曙 3 吴德平 2 张金荣 1 蒋兆荣 1 焦峰 3 王建国 3

单位：1.江苏省淮安市解放军第八二医院感染内科江苏淮安 223001 2.江苏省淮安市解放军第八二医院中心实验室江苏淮安 223001 3.江苏省淮安市解放军第八二医院医务处江苏淮安 223001

关键词：

分类号：

出版年,卷(期):页码：2015,7(3):85-88

摘要：

摘要：目的探讨树突状细胞（dendritic cells，DC）治疗核苷（酸）类和（或）干扰素经治慢性乙型肝炎降低HBsAg、HBeAg定量效果。方法自体血分离培养树突状细胞（DC）回输治疗核苷（酸）类和（或）干扰素经治慢性乙型肝炎（CHB）42例，并与348例对照组比较HBsAg、HBeAg定量变化情况。结果 DC治疗组与对照组HBsAg下降显效率分别为28.2%、18.9%；HBeAg定量下降显效率分别为41%和29.6%，二组HBeAg下降显效率无显著差异（P = 0.31）。结论自体DC回输可以打破部分慢性乙型肝炎患者的免疫耐受，诱导一定的免疫应答，提高乙型肝炎综合抗病毒治疗效果。

Abstract: Objective To investigate the effect of dendritic cells (DC) on reducing HBsAg and HBeAg levels of chronic hepatitis B (CHB) patients treated with nucleoside (nucleotide) and (or) interferon. Methods Autologous dendritic cells were separated and cultured and re-infused into 42 cases of respective CHB
patients who had been treated with nucleos(t)ide and (or) interferon. Their HBsAg and HBeAg levels were compared with those 348 patients in control group. Results Markedly effective rates of the reduction of HBsAg levels were 28.2% in treatment group and 18.9% in control group, while those of the reduction of
HBeAg levels in both groups were 41% and 29.6%, respectively. No significant difference in markedly effective rate of HBeAg reduction was found between the two groups (P = 0.31). Conclusions Re-infusion of autologous dendritic cells can break immune tolerance in part of the CHB patients and induce some immune response, and enhance the comprehensive effect of antiviral treatment for hepatitis B.

基金项目：

作者简介：

参考文献：

服务与反馈：

【文章下载】【加入收藏】